1. [Effectiveness of docetaxel plus cisplatin in large cell lung cancer showing little response to prior chemotherapy with MVP].
- Author
-
Saito T, Ishida T, Aoki H, Kuwahara K, Minegishi Y, Watanabe K, Okano T, Hashimoto K, Hayashihara K, Watanabe S, Nemoto E, Fukai S, and Yanai N
- Subjects
- Antineoplastic Combined Chemotherapy Protocols administration & dosage, Cisplatin administration & dosage, Docetaxel, Drug Administration Schedule, Humans, Male, Middle Aged, Mitomycin administration & dosage, Paclitaxel administration & dosage, Treatment Failure, Vindesine administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carcinoma, Large Cell drug therapy, Lung Neoplasms drug therapy, Paclitaxel analogs & derivatives, Taxoids
- Abstract
The present patient was a 53-year-old male who had large cell lung cancer of c-T4N1M0. We administered multi-drug regimen including mitomycin C, vindesine and cisplatin (CDDP) because of cancer invasion into the great vessels seen on a chest CT. After 3 courses, the cancer showed no change in size. Therefore, we adopted chemotherapy of docetaxel (Taxotere: TXT) and CDDP. After 4 courses, the size of the mass had decreased (partial response). The only major toxic defect was grade 3 neutropenia. A good response to TXT and CDDP could lead to complete resection of lung cancer. It is suggested that TXT is effective in the treatment of large cell lung cancer.
- Published
- 2000